0001437749-26-015083
SEC filingQ1 revenue grew modestly 3.7% to $34.8M amid steady demand, but profitability declined sharply with operating income down 35.2% to $5.6M due to higher direct expenses from technology investments, partially offset by stronger cash generation from working capital timing.
National Research Corporation reported Q1 2026 results showing revenue growth tempered by profitability pressures from ongoing investments, with cash flows demonstrating resilience.
Revenue rose 3.7% to $34.8 million from $33.6 million in the prior year quarter, indicating sustained demand for the company's research and healthcare analytics services. This modest increase provides a stable top-line foundation despite broader market dynamics.
Net income declined 44.3% to $3.2 million from $5.8 million, with diluted EPS at $0.14 versus $0.25. The provision for income taxes decreased primarily due to lower taxable income, though partially offset by a higher effective tax rate, further impacting bottom-line results.
Cash provided by operating activities strengthened to $7.2 million from $6.6 million. This improvement occurred primarily due to working capital changes, including timing of trade accounts receivable and prepaid expenses from billings and payments, as well as higher deferred revenue—partially offsetting the decrease in net income. Management defines Free Cash Flow as net cash from operations less capital expenditures, resulting in $5.3 million after $1.8 million in capex (down from $3.0 million). This metric offers valuable insight into liquidity for management and investors. The decrease in cash and cash equivalents was partially offset by these operating cash inflows.
Despite a working capital deficit at quarter-end, management believes existing liquidity sources—including cash, borrowing availability, and operating cash flows—will suffice for projected capital needs and debt maturities. These dynamics underscore NRC's focus on technology-driven growth while maintaining cash generation to support operations.